Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Neuroimmunol ; 135(1-2): 47-55, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12576223

ABSTRACT

This study provides the first evidence for catecholamine synthesis and release in the RAW264.7 cell line, an important macrophage model. Although catecholamines were low in unstimulated cells, activation with lipopolysaccharide (LPS) induced tyrosine hydroxylase (TH) mRNA and increased extracellular norepinephrine and intracellular dopamine within 48 h. The catecholamine synthesis inhibitor alpha-methyl-para-tyrosine (alpha-mpt) decreased extracellular norepinephrine levels, suggesting release and rapid turnover of newly synthesized norepinephrine. High concentrations of dopamine or norepinephrine (>/=100 microM) decreased proliferation and increased apoptosis of macrophages. These anti-proliferative effects were prevented by simultaneous treatment with the anti-oxidant ascorbic acid. Pre-incubation with a glutathione synthesis inhibitor (L-buthionine-[S,R]-sulfoximine [L-BSO]) increased sensitivity to catecholamine-stimulated apoptosis, suggesting that glutathione protects macrophages from both endogenous and exogenous catecholamines.


Subject(s)
Catecholamines/metabolism , Macrophages/metabolism , Animals , Apoptosis/drug effects , Catecholamines/pharmacology , Cell Division/drug effects , Cell Line , Lipopolysaccharides/pharmacology , Macrophages/drug effects , Mice , RNA, Messenger/analysis , Tyrosine 3-Monooxygenase/genetics , alpha-Methyltyrosine/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...